An investigational drug is being tried on healthy volunteers for its safety and pharmacokinetic properties. Which of the following stages in the drug development process does this scenario most closely describe?
Select Your Answer:
Phase I trials aim to understand the safety and pharmacokinetic properties of an investigational drug.
Phase II trials aim to evaluate the efficacy of the a drug on small number of patients.
Phase III trials are done on a large number of patients to compare the efficacy of the new drug to that of a standard therapy or placebo.
*eMedicine, Google Scholar, UpToDate, WheelessOnline, and DermNet are not affiliated with StatPearls. We do not control their content or advertising.
Adult Lab Normals
Pediatric Lab Normals
Towards the first targeted therapy for triple-negative breast cancer: repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor., Ahmed K,Koval A,Xu J,Bodmer A,Katanaev VL,, Cancer letters, 2019 Feb 13 [PubMed PMID: 30771433]
Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas., Li X,Wang C,Lin Z,Zhao M,Ren X,Zhang X,Jiang Z,, Neurosurgical review, 2019 Feb 15 [PubMed PMID: 30771118]
EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC., Yin Y,Sun M,Zhan X,Wu C,Geng P,Sun X,Wu Y,Zhang S,Qin J,Zhuang Z,Liu Y,, Journal of experimental & clinical cancer research : CR, 2019 Feb 15 [PubMed PMID: 30770740]
Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!, Hall AB,Brilakis ES,, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019 Feb 15 [PubMed PMID: 30770658]
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion., Andersen KM,Kelly A,Lyddiatt A,Bingham CO 3rd,Bykerk VP,Batterman A,Westreich J,Jones MK,Cross M,Brooks P,March L,Shea B,Tugwell P,Simon LS,Christensen R,Bartlett SJ,, The Journal of rheumatology, 2019 Feb 15 [PubMed PMID: 30770516]